Prevention of epiretinal membrane traction progression with topical indomethacin treatment: a case report and mini literature review
This case report explores the potential of 0.5% indomethacin eye drops (Indo0.5) in preventing the progression of epiretinal membrane traction. A 72-year-old patient with progressive vitreomacular traction was treated with Indo0.5, leading to a significant decrease in intraretinal cyst within 8 mont...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BioExcel Publishing Ltd
2025-06-01
|
| Series: | Drugs in Context |
| Subjects: | |
| Online Access: | https://www.drugsincontext.com/prevention-of-epiretinal-membrane-traction-progression-with-topical-indomethacin-treatment-a-case-report-and-mini-literature-review/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849431122143870976 |
|---|---|
| author | Amedeo Lucente Andrea Taloni Federico Fava Giuseppe Giannaccare |
| author_facet | Amedeo Lucente Andrea Taloni Federico Fava Giuseppe Giannaccare |
| author_sort | Amedeo Lucente |
| collection | DOAJ |
| description | This case report explores the potential of 0.5% indomethacin eye drops (Indo0.5) in preventing the progression of epiretinal membrane traction. A 72-year-old patient with progressive vitreomacular traction was treated with Indo0.5, leading to a significant decrease in intraretinal cyst within 8 months, complete resorption after 16 months and full restoration of the retinal profile after 22 months. A mini literature review highlights the anti-inflammatory effects of indomethacin for various conditions affecting the anterior segment and suggests that the 0.5% concentration may also be effective in managing retinal inflammation. Indo0.5 could be a non-invasive option for slowing epiretinal membrane traction progression, supporting further research to optimize treatment strategies. |
| format | Article |
| id | doaj-art-6440d180e1ad4dcba83fd4f64f90d46a |
| institution | Kabale University |
| issn | 1740-4398 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | BioExcel Publishing Ltd |
| record_format | Article |
| series | Drugs in Context |
| spelling | doaj-art-6440d180e1ad4dcba83fd4f64f90d46a2025-08-20T03:27:44ZengBioExcel Publishing LtdDrugs in Context1740-43982025-06-011411110.7573/dic.2025-2-4Prevention of epiretinal membrane traction progression with topical indomethacin treatment: a case report and mini literature reviewAmedeo LucenteAndrea TaloniFederico FavaGiuseppe GiannaccareThis case report explores the potential of 0.5% indomethacin eye drops (Indo0.5) in preventing the progression of epiretinal membrane traction. A 72-year-old patient with progressive vitreomacular traction was treated with Indo0.5, leading to a significant decrease in intraretinal cyst within 8 months, complete resorption after 16 months and full restoration of the retinal profile after 22 months. A mini literature review highlights the anti-inflammatory effects of indomethacin for various conditions affecting the anterior segment and suggests that the 0.5% concentration may also be effective in managing retinal inflammation. Indo0.5 could be a non-invasive option for slowing epiretinal membrane traction progression, supporting further research to optimize treatment strategies.https://www.drugsincontext.com/prevention-of-epiretinal-membrane-traction-progression-with-topical-indomethacin-treatment-a-case-report-and-mini-literature-review/epiretinal membraneinflammation0.5% indomethacin eye dropsinternal limiting membranetraction of the epiretinal membrane |
| spellingShingle | Amedeo Lucente Andrea Taloni Federico Fava Giuseppe Giannaccare Prevention of epiretinal membrane traction progression with topical indomethacin treatment: a case report and mini literature review Drugs in Context epiretinal membrane inflammation 0.5% indomethacin eye drops internal limiting membrane traction of the epiretinal membrane |
| title | Prevention of epiretinal membrane traction progression with topical indomethacin treatment: a case report and mini literature review |
| title_full | Prevention of epiretinal membrane traction progression with topical indomethacin treatment: a case report and mini literature review |
| title_fullStr | Prevention of epiretinal membrane traction progression with topical indomethacin treatment: a case report and mini literature review |
| title_full_unstemmed | Prevention of epiretinal membrane traction progression with topical indomethacin treatment: a case report and mini literature review |
| title_short | Prevention of epiretinal membrane traction progression with topical indomethacin treatment: a case report and mini literature review |
| title_sort | prevention of epiretinal membrane traction progression with topical indomethacin treatment a case report and mini literature review |
| topic | epiretinal membrane inflammation 0.5% indomethacin eye drops internal limiting membrane traction of the epiretinal membrane |
| url | https://www.drugsincontext.com/prevention-of-epiretinal-membrane-traction-progression-with-topical-indomethacin-treatment-a-case-report-and-mini-literature-review/ |
| work_keys_str_mv | AT amedeolucente preventionofepiretinalmembranetractionprogressionwithtopicalindomethacintreatmentacasereportandminiliteraturereview AT andreataloni preventionofepiretinalmembranetractionprogressionwithtopicalindomethacintreatmentacasereportandminiliteraturereview AT federicofava preventionofepiretinalmembranetractionprogressionwithtopicalindomethacintreatmentacasereportandminiliteraturereview AT giuseppegiannaccare preventionofepiretinalmembranetractionprogressionwithtopicalindomethacintreatmentacasereportandminiliteraturereview |